- 7028 malaria professionals are enjoying the free benefits of MalariaWorld today

Who's online
There are currently 5 users and 225 guests online.
Online users
- Events
- ric.ataide
- KleinE
- epivec
- krijnpaaijmans
News Flash
Latest Jobs
Events 2010
Recent blog posts
- Announcement: Malaria Course Ifakara 2012 (English)
- Job: Postdoctoral Fellow: Malaria transmission-blocking research (Entomologist/Malariologist)
- Job: ACT Consortium Policy Liaison Officer
- Harnessing Immunity Genes Against Plasmodium: The Series
- We thought we were down to 655.000 deaths in 2010, right?
- Job: Postdoctoral Fellow: Malaria resistance research
- Let the sun shine
- Postdoctoral Fellows: Malaria research
- Guest Editorial: Don't fake it!
- Loop mediated amplification question
We have previously shown that a "reversed chloroquine (RCQ)" molecule, composed of a chloroquine-like moiety and a resistance reversal-like moiety, can overcome chloroquine resistance in P. falciparum
Phase III trials of the malaria vaccine, RTS,S, are now underway across multiple sites of varying transmission intensity in Africa. Heterogeneity in exposure, vaccine response and waning of efficacy may bias estimates of vaccine efficacy.